Literature DB >> 19055567

Age-related pregnancy results and further examination of bitches after aglepristone treatment of pyometra.

P Jurka1, A Max, K Hawryńska, M Snochowski.   

Abstract

The cystic endometrial hyperplasia and pyometra complex is one of the most common uterine diseases in bitches. The appearance of pharmacological preparations containing anti-progestagens created new possibilities for pyometra treatment. The aim of this study was to evaluate the curative effect of the anti-progestagen aglepristone treatment of pyometra in bitches of different ages. Twenty four bitches of different breeds, aged from 0.8 to 9.5 years (21-48 kg) exhibiting clinical pyometra symptoms (two groups - I < or = 5 years, n = 14 and II >5 years, n = 10) were evaluated. Information about the general reproductive health was collected up to 54 months after anti-progestagen treatment. Remission of clinical symptoms and return of blood chemistry results and total leucocyte count to referential values were achieved in all cases within 14 days of treatment. Bitches were naturally mated at the first, and when unsuccessful, the second oestrus after treatment. In group I, no recurrence of pyometra symptoms was observed during following cycle(s). Eight bitches (57.1%) had a full-term pregnancy and the number of newborn pups ranged from 1 to 12. None of the bitches from the group II became pregnant. In conclusion, the basic indication for conservative pharmacological treatment of pyometra is preserving female fertility and obtaining offspring. The important conditions for successful aglepristone treatment are: the young age (up to 5 years) and the lack of detectible ovarian cysts. It seems necessary to mate bitches in the first or second oestrus after finishing treatment. The efficacy of treatment can be measured by the after-treatment pregnancy rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19055567     DOI: 10.1111/j.1439-0531.2008.01288.x

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  4 in total

1.  Changes in ovaries and uterus after aglepristone administration in the third week of luteal phase of non-pregnant bitches.

Authors:  Kamil Kacprzak; Piotr Jurka; Izabella Dolka; Michał Czopowicz; Anna Ruszczak; Anna Duszewska
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

2.  Lack of in vitro effect of aglepristone on IFN-γ and IL-4 production by resting and mitogen-activated T cells of luteal bitches.

Authors:  Piotr Jurka; Lidia Szulc-Dąbrowska; Joanna Borkowska; Anna Winnicka
Journal:  BMC Vet Res       Date:  2013-10-26       Impact factor: 2.741

3.  Use of aglepristone for the treatment of P4 induced insulin resistance in dogs.

Authors:  Enrico Bigliardi; Carla Bresciani; Daniela Callegari; Francesco Di Ianni; Giorgio Morini; Enrico Parmigiani; Ezio Bianchi
Journal:  J Vet Sci       Date:  2013-12-27       Impact factor: 1.672

4.  Utero-Placental Immune Milieu during Normal and Aglepristone-Induced Parturition in the Dog.

Authors:  Miguel Tavares Pereira; Renata Nowaczyk; Selim Aslan; Serhan S Ay; Mariusz P Kowalewski
Journal:  Animals (Basel)       Date:  2021-12-19       Impact factor: 2.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.